| Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net earnings (loss) | |||||||||
-1,555,000 | 329,900 | -26,000 | -282,100 | -265,500 | -270,300 | 205,500 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash flows provided by operating activities: | |||||||||
Depreciation and amortization | |||||||||
392,500 | 428,500 | 434,000 | 383,600 | 302,600 | 226,400 | 149,900 | 0 | 0 | 0 |
Amortization of deferred loan costs | |||||||||
17,500 | 17,300 | 17,200 | 15,600 | 13,400 | 11,300 | 9,200 | 0 | 0 | 0 |
Provision for uncollectibles | |||||||||
2,765,300 | 4,080,000 | 5,276,200 | 4,371,000 | 3,221,100 | 2,014,000 | 917,200 | 0 | 0 | 0 |
Net loss on disposals and deconsolidations | |||||||||
1,300 | -3,700 | -2,400 | -9,800 | -2,400 | 6,000 | 5,700 | 0 | 0 | 0 |
Share-based compensation | |||||||||
35,600 | 40,000 | 48,700 | 48,600 | 43,600 | 38,300 | 29,400 | 0 | 0 | 0 |
Deferred income taxes | |||||||||
-985,300 | -957,700 | -481,400 | 461,200 | 429,400 | 418,700 | -78,900 | 0 | 0 | 0 |
Equity in earnings of unconsolidated affiliates | |||||||||
25,100 | 23,400 | 22,700 | 21,300 | 20,600 | 22,200 | 23,700 | 0 | 0 | 0 |
Impairment charges | |||||||||
2,480,600 | 500,700 | 500,300 | 221,600 | 221,600 | 221,600 | 221,300 | 0 | 0 | 0 |
Gain on held for sale assets | |||||||||
0 | 0 | - | - | 0 | 0 | - | - | - | - |
Other, net | |||||||||
- | - | - | - | - | - | 3,900 | 0 | 0 | 0 |
Increases (decreases) in cash, cash equivalents, restricted cash, and restricted cash equivalents net of acquisitions and dispositions: | |||||||||
Accounts receivable | |||||||||
2,926,400 | 4,252,800 | 5,455,500 | 4,627,000 | 3,352,600 | 2,131,700 | 1,003,000 | 0 | 0 | 0 |
Supplies inventory | |||||||||
-1,900 | -1,900 | -1,000 | 500 | 1,200 | 1,400 | 900 | 0 | 0 | 0 |
Prepaid and other current assets | |||||||||
18,700 | 18,000 | 13,800 | 26,800 | 23,700 | 32,000 | 42,300 | 0 | 0 | 0 |
Accounts payable | |||||||||
-19,900 | -25,800 | -12,100 | -3,000 | -4,400 | -4,400 | -1,600 | 0 | 0 | 0 |
Accrued expenses and other liabilities | |||||||||
-209,800 | 117,100 | 9,400 | 31,700 | -14,900 | -71,300 | 2,300 | 0 | 0 | 0 |
Other, net | |||||||||
9,100 | 5,400 | -4,400 | -16,800 | -22,200 | -17,800 | -17,300 | 0 | 0 | 0 |
Net cash flows provided by operating activities | |||||||||
443,400 | 736,600 | 797,400 | 629,800 | 603,500 | 436,200 | 419,800 | 0 | 0 | 0 |
Cash flows from investing activities: | |||||||||
Acquisitions and related expenses, net of cash acquired | |||||||||
400,600 | 756,300 | 757,800 | 737,000 | 598,900 | 464,400 | 394,300 | 0 | 0 | 0 |
Acquisition of property and equipment | |||||||||
197,000 | 213,500 | 208,900 | 174,000 | 152,600 | 124,500 | 99,500 | 0 | 0 | 0 |
Net proceeds from sale of medical transportation business | |||||||||
0 | 0 | - | - | 0 | 0 | - | - | - | - |
Purchases of marketable securities | |||||||||
74,500 | 78,400 | 24,500 | 19,800 | 17,000 | 5,000 | 1,600 | 0 | 0 | 0 |
Maturities of marketable securities | |||||||||
34,300 | 31,700 | 15,000 | 8,000 | 8,100 | 2,100 | 3,800 | 0 | 0 | 0 |
Other, net | |||||||||
28,500 | 22,100 | 5,900 | 7,000 | -10,700 | -9,500 | 9,300 | 0 | 0 | 0 |
Net cash flows provided by (used in) investing activities | |||||||||
1,613,400 | 1,241,100 | -982,100 | -764,000 | -552,500 | -385,100 | -303,700 | 0 | 0 | 0 |
Cash flows from financing activities: | |||||||||
Proceeds from long-term borrowings | |||||||||
133,000 | 923,700 | 801,900 | 4,880,400 | 4,990,400 | 4,496,700 | 4,509,200 | 0 | 0 | 0 |
Repayment on long-term borrowings | |||||||||
1,855,100 | 2,154,000 | 341,700 | 4,175,800 | 4,277,600 | 4,033,700 | 4,062,100 | 0 | 0 | 0 |
Distributions to noncontrolling interests | |||||||||
223,900 | 222,400 | 229,800 | 230,100 | 231,300 | 231,600 | 227,900 | 0 | 0 | 0 |
Proceeds from issuance of common stock upon exercise of stock options | |||||||||
- | - | - | - | - | - | 700 | 0 | 0 | 0 |
Repurchase of common stock | |||||||||
- | - | - | - | - | - | 6,100 | 0 | 0 | 0 |
Other, net | |||||||||
-5,300 | -15,400 | -17,500 | -15,000 | -21,800 | -11,600 | -1,600 | 0 | 0 | 0 |
Net cash flows provided by (used in) financing activities | |||||||||
-1,958,900 | -1,475,700 | 205,300 | 347,400 | 356,000 | 116,300 | 108,800 | 0 | 0 | 0 |
Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||||||
97,900 | 502,000 | 20,600 | 213,200 | 407,000 | 167,400 | 224,900 | 0 | 0 | 0 |